Results 71 to 80 of about 5,533 (163)

Fatal Hemorrhagic Transformation of Acute Cerebral Infarction After the Use of Abciximab [PDF]

, 2000
Raymond T.F. Cheung, David S.W. Ho
openalex   +1 more source

Abciximab-Associated Pseudothrombocytopenia [PDF]

, 2000
Michael B. Holmes, Samer Kabbani, Matthew W. Watkins, Robert W. Battle, David J. Schneider   +4 more
openalex   +1 more source

Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Patients Undergoing Percutaneous Coronary Intervention [PDF]

, 2000
Dean J. Kereiakes
openalex   +1 more source

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?

Vascular Health and Risk Management, 2006
Matthew A Silva1, Jennifer L Donovan1,3, Pritesh J Gandhi2, Gregory A Volturo31Massachusetts College of Pharmacy and Health Sciences, Department of Pharmacy Practice, Worcester, MA, USA; 2Alexion Pharmaceuticals, Inc., Cheshire, CT, USA; 3UMass Memorial ...
Matthew A Silva, Jennifer L Donovan, Pritesh J Gandhi, Gregory A Volturo   +3 more
doaj  

Acute Platelet Inhibition With Abciximab Does Not Reduce In-Stent Restenosis [PDF]

, 2000
Iqbal Malik, Michael Poullis
openalex   +1 more source

Elective or selective use of abciximab? [PDF]

, 2000
Robert J. Butler, NJ Samani
openalex   +1 more source

The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions

, 1999
Verghese Mathew, Diane E. Grill, Christopher G. Scott, J. Aaron Grantham, Henry H. Ting, Kirk N. Garratt, David R. Holmes   +6 more
openalex   +1 more source

Assessment of change of coronary artery flow using corrected TIMI frame count following abciximab adminstration during primary angioplasty for acute myocardial infarction [PDF]

, 2000
Hae Ok Jung, Ki Bae Seung, Jung Won Jang, Sang Hyun Lim, Ki Yuk Jang, Hyo Young Lim, Wook Sung Chung, Jong Jin Kim, Jang Sung Chae, Jae Hyung Kim, Soon Jo Hong, Kyu Bo Choi   +11 more
openalex   +1 more source

Antiagregantes plaquetarios: mecanismos de acción y riesgos asociados al uso Platelet antiaggregants: mechanisms of action and use asocied risks

Vitae, 2009
Las Enfermedades Cardiovasculares son la principal causa de muerte en el mundo. Junto con los esfuerzos en disminuir los factores de riesgo cardiovascular, se recurre a diversos medicamentos para disminuir la morbimortalidad asociada a estas enfermedades,
Iván F PALOMO G, Constanza I TORRES U, Rodrigo E MOORE-CARRASCO, Marcelo A ALARCÓN L, Patricio J MARAGAÑO L   +4 more
doaj  

Intra-arterial thrombin injection of an ascending aortic pseudoaneurysm complicated by transient ischemic attack and rescued with systemic abciximab [PDF]

, 2001
Peter H. Lin, Ruth L. Bush, Frank Tong, Elliot L. Chaikof, Louis G. Martin, Alan B. Lumsden   +5 more
openalex   +1 more source